Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2011 2
2014 1
2015 2
2016 1
2018 2
2020 5
2021 3
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V, Gschossmann J, Layer P. Andresen V, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):658-666. doi: 10.1016/S2468-1253(20)30056-X. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277872 Clinical Trial.
BACKGROUND: Bifidobacterium bifidum MIMBb75 is one of a few probiotic strains that have been shown to be effective in the treatment of irritable bowel syndrome (IBS) and its symptoms. ...No serious adverse events occurred in the B bifidum …
BACKGROUND: Bifidobacterium bifidum MIMBb75 is one of a few probiotic strains that have been shown to be effective in the trea …
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. Skrzydło-Radomańska B, et al. Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. Nutrients. 2020. PMID: 32635661 Free PMC article. Clinical Trial.
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifido …
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing prob …
The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia.
Marras L, Caputo M, Bisicchia S, Soato M, Bertolino G, Vaccaro S, Inturri R. Marras L, et al. Microorganisms. 2021 Apr 14;9(4):836. doi: 10.3390/microorganisms9040836. Microorganisms. 2021. PMID: 33919907 Free PMC article. Review.
The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. ...Bifidobacterium bifidum showed an …
The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, …
Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
Quigley EM. Quigley EM. Aliment Pharmacol Ther. 2011 Jul;34(1):100-1; author reply 101. doi: 10.1111/j.1365-2036.2011.04671.x. Aliment Pharmacol Ther. 2011. PMID: 21631550 Free article. No abstract available.
Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism.
Ku S, Park MS, Ji GE, You HJ. Ku S, et al. Int J Mol Sci. 2016 Sep 14;17(9):1544. doi: 10.3390/ijms17091544. Int J Mol Sci. 2016. PMID: 27649150 Free PMC article. Review.
Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products and as a dairy starter since 2000. The various bio-functional effects and potential for industrial application of B. bifidum BGN4 has …
Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products …
Bacterial therapy for irritable bowel syndrome.
Talley NJ, Irani M, Keely S. Talley NJ, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):627-629. doi: 10.1016/S2468-1253(20)30079-0. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277873 No abstract available.
Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S, Mora D, Gschwender M, Popp K. Guglielmetti S, et al. Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. Aliment Pharmacol Ther. 2011. PMID: 21418261 Free article. Clinical Trial.
BACKGROUND: Recent research suggests that an imbalance of the intestinal microbiota and a dysfunctional intestinal barrier might trigger irritable bowel syndrome (IBS). As probiotics have been reported to restore the intestinal microbiota and the gut barrier, …
BACKGROUND: Recent research suggests that an imbalance of the intestinal microbiota and a dysfunctional intestinal barrier might trigger …
Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.
Shin SY, Park S, Moon JM, Kim K, Kim JW, Chun J, Lee TH, Choi CH; Microbiome Research Group of the Korean Society for Neurogastroenterology and Motility. Shin SY, et al. J Neurogastroenterol Motil. 2022 Oct 30;28(4):642-654. doi: 10.5056/jnm21202. J Neurogastroenterol Motil. 2022. PMID: 36250371 Free PMC article.
BACKGROUND/AIMS: We aim to evaluate the differences in the microbiome of responders and non-responders, as well as predict the response to probiotic therapy, based on fecal microbiome data in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) …
BACKGROUND/AIMS: We aim to evaluate the differences in the microbiome of responders and non-responders, as well as predict the response to p …
Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats.
Wang X, Fukui H, Ran Y, Xu X, Ebisutani N, Nakanishi T, Tanaka Y, Maeda A, Makizaki Y, Tomita T, Oshima T, Miwa H. Wang X, et al. Biomedicines. 2021 Jun 3;9(6):641. doi: 10.3390/biomedicines9060641. Biomedicines. 2021. PMID: 34204993 Free PMC article.
Although probiotics may be useful for the treatment of irritable bowel syndrome (IBS), it is unclear how probiotics play a role in colonic mucosal integrity and immunity. Here, we aimed to investigate the effect of Bifidobacterium bifidum G9-1 ( …
Although probiotics may be useful for the treatment of irritable bowel syndrome (IBS), it is unclear how probiotics pla …
20 results